col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


43 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Annals of Clinical Microbiology and Antimicrobials
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―20 Long COVID clinical evaluation, research and impact on society: a global expert consensus Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, Anna E. S. Brooks, Julien Wist, Yaneer Bar-Yam, et al. (+21)
2 [GO] 2024―Okt―10 The evaluation of SARS-CoV-2 mutations at the early stage of the pandemic in Istanbul population Yavuz Uyar, Selen Zeliha Mart Kömürcü, Yakup Artik, Nevra Pelin Cesur, Arzu Tanrıverdi, Kamuran Şanlı
3 [GO] 2024―Jul―18 Molecular epidemiology of Acinetobacter baumannii during COVID-19 at a hospital in northern China Xinlin Huang, Nianzhi Ning, Deyu Li, Suming Chen, Liangyan Zhang, Huan Wang, et al. (+4)
4 [GO] 2024―Feb―01 Integrated approach for detection of SARS-CoV-2 and its variant by utilizing LAMP and ARMS-PCR Maryam Nawab, Syeda Kiran Riaz, Eiman Ismail, Alfar Ahamed, Aaysha Tariq, Muhammad Faraz Arshad Malik, et al. (+7)
5 [GO] 2023―Nov―09 Correction: Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study Ángel Estella, Ignacio Martín-Loeches, María Recuerda Núñez, Clara González García, Liliana Marcela Pesaresi, Alvaro Antón Escors, et al. (+2)
6 [GO] 2023―Okt―14 Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya Jeniffer Munyiva Mutua, John Mwaniki Njeru, Abednego Moki Musyoki
7 [GO] 2023―Okt―10 Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study Ángel Estella, Ignacio Martín Loeches, María Recuerda Núñez, Clara González García, Liliana Marcela Pesaresi, Alvaro Antón Escors, et al. (+2)
8 [GO] 2023―Aug―24 Secondary bacterial infections & extensively drug-resistant bacteria among COVID-19 hospitalized patients at the University Hospital in Kraków A Pałka, A Kujawska, DA Hareza, M Gajda, Jerzy Wordliczek, E Jachowicz-Matczak, et al. (+6)
9 [GO] 2023―Aug―07 Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API) Alexandre Naime Barbosa, Alberto Chebabo, Carlos Starling, Clevy Pérez, Clóvis Arns Cunha, David de Luna, et al. (+12)
10 [GO] 2023―Jul―07 Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia Nathalia Zuluaga, David Martínez, Carolina Hernández, Nathalia Ballesteros, Sergio Castañeda, Juan David Ramírez, Marina Muñoz
11 [GO] 2023―Jun―28 French national epidemiology of bacterial superinfections in ventilator-associated pneumonia in patients infected with COVID-19: the COVAP study Maxime Pichon, Julie Cremniter, Christophe Burucoa, Sahar Abdallah, Corentine Alauzet, Tom Alix, et al. (+111)
12 [GO] 2023―Mai―19 The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis Marzieh Soheili, Sorour Khateri, Farhad Moradpour, Pardis Mohammadzedeh, Mostafa Zareie, Seyede Maryam Mahdavi Mortazavi, et al. (+3)
13 [GO] 2023―Apr―13 A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings Linzy Elton, Muzamil Mahdi Abdel Hamid, John Tembo, Hana Elbadawi, Kwitaka Maluzi, Mohammed H. Abdelraheem, et al. (+16)
14 [GO] 2023―Mrz―21 Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients Miao Lai, Kai Wang, Chengyuan Ding, Yi Yin, Xiaoling lin, Chuanjun Xu, et al. (+2)
15 [GO] 2023―Feb―24 Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients Mehrdad Mohammadi, Mahmood Saffari, Seyed Davar Siadat, Seyed Hossein Hejazi, Mohammad Shayestehpour, Mitra Motallebi, Milad Eidi
16 [GO] 2022―Nov―19 The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study Nuttakant Nontawong, Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Mana Boonpratoom, Nawin Krailassiri, Chayaporn Boonkhum, et al. (+3)
17 [GO] 2022―Jul―03 COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials Marharyta Sobczak, Rafał Pawliczak
18 [GO] 2022―Jun―15 Monkeypox outbreaks during COVID-19 pandemic: are we looking at an independent phenomenon or an overlapping pandemic? Ramadan Abdelmoez Farahat, Abdelaziz Abdelaal, Jaffer Shah, Sherief Ghozy, Ranjit Sah, D. Katterine Bonilla-Aldana, et al. (+3)
19 [GO] 2022―Mrz―25 Vaccination of children against COVID-19: the experience in Latin America Alfonso J. Rodriguez-Morales, Darwin A. León-Figueroa, Luccio Romaní, Timothy D. McHugh, Hakan Leblebicioglu
20 [GO] 2022―Mrz―14 Diagnostic performance of RT-PCR-based sample pooling strategy for the detection of SARS-CoV-2 Miguel Hueda-Zavaleta, Cesar Copaja-Corzo, Vicente A. Benites-Zapata, Pedro Cardenas-Rueda, Jorge L. Maguiña, Alfonso J. Rodríguez-Morales
21 [GO] 2021―Dez―30 Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy Yusri Taha, Hayley Wardle, Adam B. Evans, Ewan R. Hunter, Helen Marr, Wendy Osborne, et al. (+5)
22 [GO] 2021―Dez―15 Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia Jing Peng, Ming Ni, Dunfeng Du, Yanjun Lu, Juan Song, Weiyong Liu, et al. (+6)
23 [GO] 2021―Sep―25 Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors Hans H. Liu, David Yaron, Amanda Stahl Piraino, Luciano Kapelusznik
24 [GO] 2021―Sep―14 Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia Miguel Alejandro Pinzón, Doris Cardona Arango, Juan Felipe Betancur, Santiago Ortiz, Héctor Holguín, Carolina Arias Arias, et al. (+4)
25 [GO] 2021―Sep―07 Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland Marina Gysin, Claudio Tirso Acevedo, Klara Haldimann, Elias Bodendoerfer, Frank Imkamp, Karl Bulut, et al. (+4)
26 [GO] 2021―Aug―05 Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study Mustafa Karataş, Melike Yaşar-Duman, Alper Tünger, Feriha Çilli, Şöhret Aydemir, Volkan Özenci
27 [GO] 2021―Mai―24 Contrasting SARS-CoV-2 RNA copies and clinical symptoms in a large cohort of Colombian patients during the first wave of the COVID-19 pandemic Santiago A. Quiroga, Carolina Hernández, Sergio Castañeda, Paula Jimenez, Laura Vega, Marcela Gomez, et al. (+8)
28 [GO] 2021―Mai―22 Comparative evaluation of six nucleic acid amplification kits for SARS-CoV-2 RNA detection Shuang Wu, Xiaolu Shi, Qiongcheng Chen, Yixiang Jiang, Le Zuo, Lei Wang, et al. (+9)
29 [GO] 2021―Mai―21 Repurposing of antibiotics for clinical management of COVID-19: a narrative review Abdourahamane Yacouba, Ahmed Olowo-okere, Ismaeel Yunusa
30 [GO] 2021―Mai―18 COVID-19: breaking down a global health crisis Saad I. Mallah, Omar K. Ghorab, Sabrina Al-Salmi, Omar S. Abdellatif, Tharmegan Tharmaratnam, Mina Amin Iskandar, et al. (+5)
31 [GO] 2021―Apr―27 Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study Aziz Ogutlu, Oguz Karabay, Unal Erkorkmaz, Ertugrul Guclu, Seher Sen, Abdulkadir Aydin, Mehmet Koroglu
32 [GO] 2021―Mrz―16 The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis Erfan Kazemi, Reihane Soldoozi Nejat, Fatemeh Ashkan, Hossein Sheibani
33 [GO] 2021―Jan―18 MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Mohammed A. Alqumber, Shafiul Haque, Shailesh Kumar Patel, et al. (+7)
34 [GO] 2021―Jan―12 A first probable case of SARS-CoV-2 reinfection in Colombia Whilken Novoa, Hollman Miller, Salim Mattar, Álvaro A. Faccini-Martínez, Ricardo Rivero, Hector Serrano-Coll
35 [GO] 2021―Jan―06 Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study Yanjiao Lu, Zhenli Huang, Meijia Wang, Kun Tang, Shanshan Wang, Pengfei Gao, et al. (+3)
36 [GO] 2020―Dez―07 Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean Salim Mattar, Caty Martinez-Bravo, Ricardo Rivero, Héctor Contreras, Álvaro A. Faccini-Martínez, Camilo Guzman-Teran, et al. (+13)
37 [GO] 2020―Nov―30 COVID-19 vaccine development: What lessons can we learn from TB? Hussain A. Safar, Abu Salim Mustafa, Timothy D. McHugh
38 [GO] 2020―Sep―02 SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, et al. (+9)
39 [GO] 2020―Jul―18 Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps Cecilia Acuti Martellucci, Ranjit Sah, Ali A. Rabaan, Kuldeep Dhama, Cristina Casalone, Kovy Arteaga-Livias, et al. (+10)
40 [GO] 2020―Mai―30 Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19 Khan Sharun, Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Bhoj Raj Singh, et al. (+4)
41 [GO] 2020―Mai―23 Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes Toyin Togun, Beate Kampmann, Neil Graham Stoker, Marc Lipman
42 [GO] 2020―Mai―15 Plasma CRP level is positively associated with the severity of COVID-19 Wei Chen, Kenneth I. Zheng, Saiduo Liu, Zhihan Yan, Chongyong Xu, Zengpei Qiao
43 [GO] 2020―Apr―24 Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin José Millán-Oñate, William Millan, Luis Alfonso Mendoza, Carlos Guillermo Sánchez, Hugo Fernandez-Suarez, D. Katterine Bonilla-Aldana, Alfonso J. Rodríguez-Morales
 [1] 

43 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.070 sec